BL-B01D1

(Synonyms: Izalontamab Brengitecan)
Customer Review

Based on 1 Customer Validation

BL-B01D1 is a bispecific ADC, which targets EGFR and HER3 through bispecific antibody Izalontamab (HY-P99676), and exhibits cytotoxicity against various cancer cells via inhibition of DNA replication and DNA synthesis by its ADC toxin ED04 (HY-153891). BL-B01D1 can be used in the study of cancer.

For research use only. We do not sell to patients.

  • Purity: 99.65%
  • Molecular Weight:205830.00
  • Storage:

    -80°C, protect from light

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00